On April 19, 2024, the U.S. Environmental Protection Agency announced the designation of two per- and polyfluoroalkyl substances (PFAS)—perfluorooctanoic acid (PFOA) and perfluorooctanesulfonic acid (PFOS) and their salts and structural isomers—as hazardous substances under the Comprehensive Environmental Response, Compensation and Liability Act (CERCLA).[1] In its designation, the EPA has identified over 85 industries it believes are most likely to be directly or indirectly affected by the designation.
Vance Street Capital Closes Third Fund With $775 Million
By Trey Andrews
Vance Street Capital has announced it has closed its fourth fund, Vance Street Capital IV, with $775 million.
The fund exceeded its target of $550 million in commitments.
Through the new fund, the firm indicated it will continue to pursue businesses in the medical and life science sectors as well as a few others.
Prepping for a Sale: Strategies for Provider Groups, With Marc Anderson
From a seller’s perspective, how does a provider group get ready for a sale process?
In this episode of The Corner Series, McGuireWoods’ Geoff Cockrell interviews Marc Anderson, managing partner of The Belay Group, on the nuances of preparing companies, particularly in healthcare services, for a sale process. The discussion highlights the…
Highlights from the 2024 SIFMA Anti-Money Laundering and Financial Crimes Conference on the Corporate Transparency Act
On May 6, 2024, the Financial Crimes Enforcement Network (“FinCEN”) Director Andrea Gacki, Acting Chief of the Enforcement Division Steve Hsieh, Acting Associate Director of the Policy Division James Martinelli, and other key industry leaders, convened at SIFMA’s Anti-Money Laundering and Financial Crimes conference in New York to discuss, among other things, FinCEN’s priorities for the Corporate Transparency Act (“CTA”).
Healthcare & Life Sciences Private Equity Deal Tracker: Knox Lane Acquires All Star Healthcare Solutions
Knox Lane has announced the acquisition of All Star Healthcare Solutions.
All Star, founded in 2003 and based in Deerfield Beach, Florida, is a healthcare staffing firm that places physicians and advanced practitioners on locum tenens assignments and in permanent positions at health systems, hospitals and other healthcare facilities throughout the country.
Latticework Closes Fund With $345 Million
Latticework Capital Management (LCM) has announced the closing of its latest fund with $345 million in commitments.
The new fund, LCM Healthcare Fund II, was oversubscribed, with the firm originally target $275 million. The fund will pursue control investments in founder-led lower middle market healthcare companies.
Latticework, based in Dallas, makes control equity investments…
Healthcare & Life Sciences Private Equity Deal Tracker: Kain Invests in Essen Health Care
By Trey Andrews
Kain Capital has announced an investment in Essen Health Care.
Essen, founded in 1999 and based in Bronx, New York, is an independent, multi-specialty healthcare provider with over 450 practitioners across Manhattan, Bronx, Queens, Staten Island, Long Island and Westchester County.
Kain, founded in 2014 and based in New York, is a private…
Investment Considerations for Dermatology and Aesthetics Practices, With Clint Bundy and Stewart Carlin
Dermatology and aesthetics practices took off after the Great Recession, thrived during Covid, and show no signs of slowing down. What makes dermatology and aesthetics such desirable investments?
In this episode of The Corner Series, McGuireWoods’ Geoff Cockrell chats with Clint Bundy and Stewart Carlin, managing directors of the Bundy Group,…
Healthcare & Life Sciences Private Equity Deal Tracker: WindRose Acquires SubjectWell
WindRose Health Investors has announced its acquisition of SubjectWell.
SubjectWell, founded in 2012 and based in Austin, Texas, is a patient access marketplace that connects people with health conditions to care options.
WindRose, based in New York, pursues control equity investments in healthcare companies. Founded in 2000, the firm invests in a broad range of…
Milk Coverage for All Its Worth While the “Steaks” Are High: An Insurance Primer on Coverage for the H5N1 Bird Flu Outbreak
Dairy is the latest round of kitchen staples to suffer from viral diagnoses. In a first, the H5N1 virus, commonly referred to as the bird flu, is rapidly spreading through US cattle herds.[1] The virus has already been detected in pasteurized milk sitting on grocery store shelves.[2] The World Health Organization labeled the outbreak an animal pandemic, but fears of animal to human transmission are rising.[3] To prepare for the potential financial impact of this looming outbreak, livestock owners and businesses should consider their insurance policies as possible sources of recovery.